These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15490430)

  • 41. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
    Lindgren P; Stenestrand U; Malmberg K; Jönsson B
    Clin Ther; 2005 Jan; 27(1):100-10. PubMed ID: 15763611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost effectiveness in Canada of eptifibatide treatment for acute coronary syndrome patients using PURSUIT subgroup analysis.
    Brown R; Armstrong P;
    Can J Cardiol; 2003 Feb; 19(2):161-6. PubMed ID: 12601441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Confidence intervals construction for difference of two means with incomplete correlated data.
    Li HQ; Tang NS; Yi JY
    BMC Med Res Methodol; 2016 Mar; 16():31. PubMed ID: 26969507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parametric modelling of cost data: some simulation evidence.
    Briggs A; Nixon R; Dixon S; Thompson S
    Health Econ; 2005 Apr; 14(4):421-8. PubMed ID: 15685641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bootstrap confidence intervals and bias correction in the estimation of HIV incidence from surveillance data with testing for recent infection.
    Carnegie NB
    Stat Med; 2011 Apr; 30(8):854-65. PubMed ID: 21432879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Weighted log-rank tests for clustered censored data: Saddlepoint
    Abd El-Raheem AEM; Abd-Elfattah EF
    Stat Methods Med Res; 2020 Sep; 29(9):2629-2636. PubMed ID: 32114903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Finite sample pointwise confidence intervals for a survival distribution with right-censored data.
    Fay MP; Brittain EH
    Stat Med; 2016 Jul; 35(16):2726-40. PubMed ID: 26891706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A bootstrap approach for lower injury levels of the risk curves.
    Lu YC; Untaroiu CD
    Comput Methods Programs Biomed; 2012 Jun; 106(3):274-86. PubMed ID: 21549443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimating medical care costs under conditions of censoring.
    Raikou M; McGuire A
    J Health Econ; 2004 May; 23(3):443-70. PubMed ID: 15120465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-parametric estimators of a monotonic dose-response curve and bootstrap confidence intervals.
    Dilleen M; Heimann G; Hirsch I
    Stat Med; 2003 Mar; 22(6):869-82. PubMed ID: 12627406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Commentary: Alternative safe, effective and cost-efficient dosing for eptifibatide in low-risk patients.
    Helmy T; Effat M
    J Invasive Cardiol; 2006 Oct; 18(10):492-3. PubMed ID: 17042095
    [No Abstract]   [Full Text] [Related]  

  • 52. Using clopidogrel in non-ST-segment elevation acute coronary syndrome patients: a cost-utility analysis in Spain.
    Latour-Pérez J; Navarro-Ruiz A; Ridao-López M; Cervera-Montes M
    Value Health; 2004; 7(1):52-60. PubMed ID: 14720130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Confidence intervals for cost-effectiveness ratios: a comparison of four methods.
    Polsky D; Glick HA; Willke R; Schulman K
    Health Econ; 1997; 6(3):243-52. PubMed ID: 9226142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38.
    Mahoney EM; Wang K; Arnold SV; Proskorovsky I; Wiviott S; Antman E; Braunwald E; Cohen DJ
    Circulation; 2010 Jan; 121(1):71-9. PubMed ID: 20026770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cost of clopidogrel use in atrial fibrillation in the ACTIVE-A trial.
    Lamy A; Tong W; Gao P; Chrolavicius S; Gafni A; Yusuf S; Connolly SJ
    Can J Cardiol; 2012; 28(1):95-101. PubMed ID: 21983111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calculating confidence intervals for prediction error in microarray classification using resampling.
    Jiang W; Varma S; Simon R
    Stat Appl Genet Mol Biol; 2008; 7(1):Article8. PubMed ID: 18312213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abciximab therapy in percutaneous intervention: economic issues in the United States.
    Goklaney AK; Murphy JD; Hillegass WB
    Eur Heart J; 1998 Apr; 19 Suppl D():D52-8. PubMed ID: 9597522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of methods for the construction of confidence interval for relative risk in stratified matched-pair designs.
    Tang NS; Li HQ; Tang ML
    Stat Med; 2010 Jan; 29(1):46-62. PubMed ID: 19856277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Non-parametric methods for estimating confidence intervals around the incremental cost-effectiveness ratio].
    Petrinco M; Gregori D; Lazzarato F; Brunello F; Veltri A; Berchialla P; Pagano E
    Epidemiol Prev; 2008; 32(6):307-13. PubMed ID: 19353965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous confidence intervals of risk differences in stratified paired designs.
    Tang NS; Qiu SF; Tang ML; Zou GY; Yu D
    J Biopharm Stat; 2013 Mar; 23(2):361-77. PubMed ID: 23437944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.